Dicerna Pharmaceuticals
DRNA
#4038
Rank
NZ$5.41 B
Marketcap
NZ$69.55
Share price
0.00%
Change (1 day)
17,649.91%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -NZ$0.17 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2020 the company made an earning of -NZ$0.2 Billion, an increase over its 2019 earnings that were of -NZ$0.23 Billion.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-NZ$0.17 Billion-15.21%
2020-NZ$0.2 Billion-11.52%
2019-NZ$0.23 Billion38.33%
2018-NZ$0.17 Billion46.14%
2017-NZ$0.12 Billion1.8%
2016-NZ$0.11 Billion-5.58%
2015-NZ$0.12 Billion32.01%
2014-NZ$86.89 Million171.79%
2013-NZ$31.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.68 B-6,022.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.11 B-9,493.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.23 B-5,814.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$86.32 Million-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.22 B-1,138.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.3 Billion 35.54%๐Ÿ‡บ๐Ÿ‡ธ USA